Annonaceous acetogenins (ACG) are natural products isolated from plants of the family Annonaceae and which have potent biological activities. Since Jolad isolated the first acetogenin (uvaricin) from Uvaria acuminata in 1982, 1) almost 400 acetogenins have been discovered, and new structural ACG will be isolated from other plants along as they are studied in depth. The reasons that ACG have drawn so much attention are not only their novel structural features but also their potent and broad activities which are seldom found in other natural compounds.
2)
Because of the wide use of ACG in pesticidal, antimalarial, antimicrobial, antiparasitic, antiprotozoal, cytotoxic activities and antitumor effects, studies on the isolation and identification of ACG as well as their action mechanism are a field presently focused on.
ACG show potent activities by inhibiting NADHubiquinone oxidoreductase (complex I) in mitochondrial respiratory chain, and complex I is the largest, most complicated and important protein complex of the mitochondrial electron transport systems, which are related to ATP production. 2, 3) Additionally, ACG are also strong inhibitors of NADH oxidase of the plasma membrane in cancer cells, but not in rat liver plasma membrane. 4) Actually, complex I can be evaluated by NADH-ubiquinone oxidoreductase activity or by NADH oxidase activity in mitochondria, although they are not equivalent. NADH oxidase activity represents an integrated activity in which NADH is oxidized and the electrons are transferred along the respiratory chain to be finally accepted by molecular oxygen. Otherwise, the assay of NADHubiquinone oxidoreductase activity is performed with ubiquinone or its analogue as electron acceptor. As ACG only inhibit complex I, the decrease of NADH oxidase activity is directly attributed to the inhibition of complex I. 5) Most studies suggest that the terminal g-lactone is essential for the potency of ACG as complex I inhibitors, although some reports propose that the alkyl chain plays a more crucial role. However, for the roles of other ring moieties have not been sufficiently emphasized. In the present study, the roles of these structural factors are discussed by three acetogenins inhibiting NADH oxidase of chicken liver mitochondria with different ring moieties in addition to terminal g-lactone, especially the non-THF type compound exhibiting inhibitory activity, and in comparison with rotenone which is the classic inhibitor of complex I.
MATERIALS AND METHODS

Materials and Reagents
Three acetogenins were isolated and purified from seeds of Annona squamosa by chromatographic procedures involving fractionation with organic solvents, silicagel separations and semi-preparative HPLC. 6, 7) The purity of the acetogenins was judged by chromatographic, 1 H-and 13 C-NMR and MS spectroscopic criteria. The reagents rotenone and NADH were purchased from Sigma. Other chemicals for isolation of mitochondria and assay of enzymes were commercial products of analytical grade. ACG and rotenone were dissolved in 95% ethanol and diluted to 10-50 mM. Squamocin C was a bis-adjacent THF type, and squamostatin B belonged to non-adjacent bis-THF type. The third acetogenin compound 1 was a non-THF type. It is a new compound and has not been formally named. Chemical structures of ACG and rotenone are shown in Fig.  1 .
Isolation of Mitochondria Chicken liver mitochondria were isolated by the method of Landolt et al. 8) The isolation medium contained 0.25 M sucrose, 0.5 mM EDTA · Na 2 , 4 mM Tris-HCl (pH 7.4). After sacrificing the chicken, livers were taken out and immediately placed in a medium containing a block of ice. The livers were washed with cold medium, cut into pieces and homogenized. The homogenates were filtered through more than six layers of gauze and centrifuged at 3000ϫg for 10 min in a Kubota 7820 centrifuge at 4°C. The supernatant was centrifuged at 12000ϫg for 15 min. Then the pellet was suspended in isolation medium with a glass tube at below 0°C. The protein concentration of mitochondria was determined by the Bradford method.
9)
Assay of NADH Oxidase The NADH oxidase activity was measured at 30°C in 1 mM EDTA · Na 2 , 20 mM potassium phosphate buffer (pH 8.0) with the liver mitochondria diluted to about 130 mg/ml in a cuvette. NADH oxidase activity was measured as the aerobic oxidation of 75 mM NADH following a decrease in the absorbance at 340 nm (eϭ6.2 mM Ϫ1 · cm Ϫ1 ) with a UV spectrophotometer. The reaction was started by the addition of NADH after the incubation of mitochondria with ACG for 2 min. The ethanol concentration did not exceed 0.5% of volume in the reaction medium after adding the ACG solution and never affected the enzyme activity.
Determination of IC 50 Values
The relationship between ACG and enzyme was analyzed by graphing the curves of the concentration of inhibitors in the assay cuvette versus percent inhibition of NADH oxidase activity. From the logarithmic regression curves, IC 50 values were calculated and taken as the final inhibitor concentration that produced 50% inhibition of NADH oxidase activity. All data in the assay were obtained from at least three independent experiments.
RESULTS AND DISCUSSION
Compared with the complicated assays of NADH oxidase activity in bovine heart submitochondrial particles (SMP), the activities of NADH oxidase in chicken liver mitochondria were lower, but the results could reflect structural activity relationships (SARs) of ACG similar to SMP. Furthermore, the experiment materials were easy to prepare and the assay procedure was very simple.
The results in Fig. 2 clearly indicate that the inhibition of NADH oxidase activity rose with the increase of inhibitor concentration. Because of their different chemical structure, ACG showed inhibitory activity in a different manner. This appeared to suggest that bis-THF type ACG were more potent than non-THF compound 1 in the assay.
According to the logarithmic regression analysis of inhibition curves in Fig. 2 , the IC 50 values of four inhibitors were calculated and are shown in Table 1 . Under the same unit conditions and in comparison with the inhibition of oxygen uptake by ACG in rat liver mitochondria, the range of these values was consistent with those reported in Ref. 8 .
As the classical inhibitor of complex I, rotenone showed a very potent inhibitory effect. However, the three ACG were completely different from rotenone in chemical structure and stereo-configuration, so the two groups were not compared in Fig. 1 . Structures of Three Acetogenins and Rotenone Used in the Assay structural factors. Considering the different extents of these inhibitors' potent activities, it was deduced that they probably belong to a similar inhibitor of NADH oxidase of mitochondria. Interestingly, these ACG had some common and regular structural characteristics, so some small stereochemical difference must lead to their different inhibitory effects. 10) Thus, the SARs of ACG reacting with NADH oxidase could be determined.
From the IC 50 values of inhibitors in Table 1 , potency ranged from strong to weak in the order squamocin C, rotenone, squamostatin B, and compound 1. Squamocin C was the most potent and compound 1 was the weakest in the assay. Squamocin C was 1.7 times more potent than squamostatin B, and about 19 times more potent than compound 1. These results demonstrated that adjacent bis-THF type ACG were more potent than other type ACG.
Squamocin C had other different structural characteristics in stereochemistry of THF from squamostatin B, in addition to the difference in position of hydroxyl groups. Because of other non-structural factors of ACG as inhibitors, for example, the dissolubility and membrane conformation, it was not completely confirmed that the changes of OH position in the chain would result in the difference in their inhibitory effects. But some reports indicated that the C 4 -OH was not important for the exhibition of potent effects. 11, 12) Compound 1 was a new structural product which was characterized by two lactones linked by a alkyl chain. Compared with the weaker potency of compound 1, the greater potency of squamocin C and squamostatin B indicated that the THF possibly played a role in the optimal inhibition. The common structure among these acetogenins was the terminal methyl-substituted-a,b-unsaturated-g-lactone. It was obviously deduced that the terminal g-lactone could be crucial for the potent activity.
Kuwabara et al. drew a conclusion about the essential factors by synthesizing new structural ACG and their analogues. 13) Contrary to the above deduction, they suggested that g-lactone and the stereochemistry of bis-THF rings were not essential for the potency, although these factors formed the usual structures of most ACG. They suggested that the flexible alkyl chain linking THF and terminal g-lactone was the most important structural factor. The alkyl chain could result in some sort of specific conformation for optimal spatial position on the enzyme and produce potent activity. [11] [12] [13] Summarizing the above results and suggestions herein, it was initially thought that the inhibitory potency of ACG probably came from the features of a terminal 2,4-disubstituted-g-lactone combined with other functional ring units (in spite of THF or lactone) by a certain length of alkyl chain. The combination of the three structural factors would offer the basic specific conformation for a spacer on NADH oxidase. Without any one of these factors, the compound would not be the specific inhibitor of mitochondrial complex I. Furthermore, the changes of alkyl chain length, the number and position of OH groups in the chain, the sorts, numbers and stereochemistry of other functional rings would influence the optimal conformation for ACG reacting with NADH oxidase in some manner. Some reports showed that a 13 carbon length of alkyl chain was optimum. 12, 13) Besides these important structures, the factors deciding the potency of ACG included dissolubility in cells and mitochondria, the conformation of mitochondrial membrane, transportation, and the metabolism of energy conservation. 14) ACG were absorbing so much because of their potent inhibitory effects on many sorts of cells. Cancer cells had an unusual action mechanism of energy conservation such as higher respiration and energy production, and this kind of energy metabolism made it more easily inhibited by ACG than normal cells. 15) However, ACG were fairly toxic to normal cells in vivo or vitro, their toxicity was hundreds or thousands of times higher than KCN, which is a virulent chemical reagent. 16) This resulted in the restricted use of ACG as anticancer drugs in the clinical area.
In fact, some useful experiments on synthesizing new antitumor ACG have been reported. [17] [18] [19] It is hoped that the SARs of ACG will be more clearly determined, thus com- 
